O. C. Guler Et Al. , "The feasibility of prostate-specific membrane antigen positron emission tomography(PSMA PET/CT)-guided radiotherapy in oligometastatic prostate cancer patients," CLINICAL & TRANSLATIONAL ONCOLOGY , vol.20, no.4, pp.484-490, 2018
Guler, O. C. Et Al. 2018. The feasibility of prostate-specific membrane antigen positron emission tomography(PSMA PET/CT)-guided radiotherapy in oligometastatic prostate cancer patients. CLINICAL & TRANSLATIONAL ONCOLOGY , vol.20, no.4 , 484-490.
Guler, O. C., Engels, B., Onal, C., Everaert, H., Van den Begin, R., Gevaert, T., ... de Ridder, M.(2018). The feasibility of prostate-specific membrane antigen positron emission tomography(PSMA PET/CT)-guided radiotherapy in oligometastatic prostate cancer patients. CLINICAL & TRANSLATIONAL ONCOLOGY , vol.20, no.4, 484-490.
Guler, O. Et Al. "The feasibility of prostate-specific membrane antigen positron emission tomography(PSMA PET/CT)-guided radiotherapy in oligometastatic prostate cancer patients," CLINICAL & TRANSLATIONAL ONCOLOGY , vol.20, no.4, 484-490, 2018
Guler, O. C. Et Al. "The feasibility of prostate-specific membrane antigen positron emission tomography(PSMA PET/CT)-guided radiotherapy in oligometastatic prostate cancer patients." CLINICAL & TRANSLATIONAL ONCOLOGY , vol.20, no.4, pp.484-490, 2018
Guler, O. C. Et Al. (2018) . "The feasibility of prostate-specific membrane antigen positron emission tomography(PSMA PET/CT)-guided radiotherapy in oligometastatic prostate cancer patients." CLINICAL & TRANSLATIONAL ONCOLOGY , vol.20, no.4, pp.484-490.
@article{article, author={O. C. Guler Et Al. }, title={The feasibility of prostate-specific membrane antigen positron emission tomography(PSMA PET/CT)-guided radiotherapy in oligometastatic prostate cancer patients}, journal={CLINICAL & TRANSLATIONAL ONCOLOGY}, year=2018, pages={484-490} }